chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Throat tightness, Vaccination site pain
Clinical narrative: injection site has mild soreness; a weird taste in my mouth; constricted my throat/a tightness in the back of my throat, as though the glands were swollen; a tightness in the back of my throat, as though the glands were swollen; constricted my throat making it uncomfortable to swallow; discomfort; felt weakness in my whole body; walking felt strange; This is a spontaneous report from a non-contactable consumer (patient) reported herself that a 41-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, batch/ lot number: EN6207), via an unknown route of administration in left arm on 13Apr2021 at 09:45 as single dose (at age of 41-years old) for COVID-19 immunization. The patient's medical history included diabetes mellitus from an unknown date to unknown if ongoing. No known allergies. Concomitant medications were not reported. No other vaccine in four weeks. Other medication in two weeks was multi-vitamins. On 13Apr2021 at 09:45, the patient experienced injection site has mild soreness even 24 hours later. Shortly after injection, during the initial 15 minutes waiting period until 5 or 6 hours later, there was a weird taste in her mouth and a tightness in the back of her throat, as though the glands were swollen and constricted her throat making it uncomfortable to swallow. There was no pain. Between a rating of 1 to 10, the discomfort level was about 5. She also felt weakness in her whole body and walking felt strange and lasted for the entire day. No COVID prior vaccination. No COVID tested post vaccination. No treatment received for events. The outcome of the events was recovered on an unspecified date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Muscle discomfort, Muscle tightness, Myalgia, Pain in extremity
Clinical narrative: I am still feeling a little warm off and on.; I am getting some muscle pain in my lower legs, like a tightness.; Some muscle issues on the side of her calf area, like the inside of her leg area is hurting; I am getting some muscle pain in my lower legs, like a tightness.; I am getting some muscle pain in my lower legs, like a tightness.; This is a spontaneous report received from a contactable consumer (patient) reported for herself that a female patient of an unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, batch/lot number: unknown, expiry date: not provided), via an unknown route of administration on 01Apr2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in Apr2021, the patient experienced "I am still feeling a little warm off and on", while she had her shot like two weeks ago. She was not running a fever or anything. She was getting some muscle pain in her lower legs, like a tightness. Some muscle issues on the side of her calf area, like the inside of her leg area was hurting. She gets a little hot too but that was the only two things she has experienced. She wanted to be sure that this was a normal thing. No, this report was not related to a study or programme. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstrual disorder
Clinical narrative: Menstruation started 3 weeks early, much heavier than normal; Menstruation started 3 weeks early, much heavier than normal; This is a spontaneous report from a contactable consumer (patient). A 24-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EWO162) via an unspecified route of administration, administered in Arm Left on 12Apr2021 15:00 (at the age of 24 years old) as dose 1, single for COVID-19 immunisation. Medical history included food allergy (Known allergies- Food allergies). No known medication allergies, no allergies to anything in COVID vaccine. The patient's concomitant medications were not reported. Patient did not received other vaccine within four weeks of COVID vaccine. Patient did not have COVID prior to vaccination. The patient experienced menstruation started 3 weeks early, much heavier than normal on 15Apr2021. No treatment were given for the adverse event. Patient did not tested for COVID post vaccination. Outcome of all the events were not resolved.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Pain in extremity
Clinical narrative: Soreness in arm for 10 days; Heaviness and shortness and breathing; Cough; This is a spontaneous report from a contactable consumer (patient). A elderly male (Age:68; Unit: Unknown) patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 06Apr2021 12:00 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history included covid-19 from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 06Apr2021 03:00 the patient experienced soreness in arm for 10 day, heaviness and shortness and breathing, cough. Outcome of Event was Not recovered.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dry throat, Heart rate, Throat tightness
Clinical narrative: my throat starting getting tight and was dry; my throat starting getting tight and was dry; This is a spontaneous report from a contactable consumer (patient). A 69-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EP7533, expiration date was not reported), via an unspecified route of administration, administered in right arm on 11Apr2021 13:15 (at the age of 69-years-old) as dose 2, single for covid-19 immunization. The patient medical history was not reported. Concomitant medications included omeprazole (20 mg), escitalopram (10 mg), simvastatin (40 mg). Other medications patient received in two weeks included omeprazole 20mg, escitalopram 10 mg, simvastatin 40mg. The patient historical vaccine included first dose of BNT162B2 (Lot number: EN6207, expiration date was not reported), via an unspecified route of administration, administered in right arm on 14Mar2021 01:00pm (at the age of 69-years-old) as dose 1, single for covid-19 immunization. Patient did not receive other vaccine in four weeks. The patient does not have any allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that on 11Apr2021 01:15 PM, on second shot - Within 10 minutes her throat starting getting tight and was dry. EMS checked her heart rate and listened to her heart. She waited an additional 30 minutes before they had her leave. Symptoms stayed for about 3 hours and went away. The patient underwent lab tests and procedures which included heart rate: unknown results on an unspecified date. No treatment was received for the adverse event. The outcome of the events was recovered on an unspecified date of 2021.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Cyanosis, Diarrhoea, Dyspnoea, Erythema
Clinical narrative: raised heart rate to 90+bpm; GI Nausea; shortness of breath; Rash on legs/ Rash on both arms and torso; Itching; loose bowel movement; Fatigue; red finger tips/bright red palms; red nail area; purple fingers to knuckle area; This is a spontaneous report from a contactable consumer (Patient). A 63-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EP7533), dose 1 via an unspecified route of administration, administered in Arm Left in Apr2021 at 02:30 PM (Age at vaccination: 63 years) as dose 1, single for covid-19 immunisation. Patient had known allergies to penicillin, sulfa, ibuprofen, flu vaccine, chocolate, pepper, citrus, chemical senitiviies. Other medical history included asthma, IBS, allergies. Concomitant medications included vitamin d [vitamin d nos] (VITAMIN D [VITAMIN D NOS]). Patient did not receive other vaccines in 4 weeks. The patient experienced raised heart rate to 90+bpm, gi nausea, shortness of breath, rash on legs/ rash on both arms and torso, itching, loose bowel movement, fatigue, red fingertips/bright red palms, red nail area, purple fingers to knuckle area in Apr2021. Immediately after injection raised heart rate to 90+bpm, GI Nausea. Within 5 minutes shortness of breath occured. 50mg of Benadryl (Diphenhydra-mine HCL) within 10 minutes of vaccine was given. Heart rate decreased to 79 bpm; shortness of breath was decreased within 25 minutes of first Benadryl dose. Rash on legs first 30 mins. Heart monitored at ER for two hours with no incident found. Pulse after discharge was 88 and blood pressure was at 164/86. There was Rash on both arms and torso later in the day along with itching. Aggressive rash/itching continued on arms for 4 for days requiring Benadryl 50mg/4 hours. Day 5 Benadryl reduced to 50mg/6 hour then 8 hours and by day 6 rash was gone. Shortness of breath subsided within 2 hours. Nausea resulted in 1 loose bowel movement within first hour post vaccine with no other GI issues. Fatigue was on day 2 only. Covid fingers day 3 thru day 5, with stronger symptoms on left hand. Symptoms changed but included red fingertips, red nail area, purple fingers to knuckle area, bright red palms. Treatment for the events included Benadryl 50mg/4 hour for 4.5 days. Patient did not have COVID prior vaccination. Patient did not test COVID post vaccination. The patient underwent lab tests and procedures which included blood pressure measurement: 164/86 on blood pressure at 164/86, raised heart rate to 90+bpm in Apr2021, heart rate: 79 bpm, Heart rate decreased to 79 bpm, heart rate: pulse after discharge was 88. The outcome of the events was recovered in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Heart rate, Heart rate increased, Nail discolouration, Nausea
Clinical narrative: raised heart rate to 90+bpm; GI Nausea; shortness of breath; Rash on legs/ Rash on both arms and torso; Itching; loose bowel movement; Fatigue; red finger tips/bright red palms; red nail area; purple fingers to knuckle area; This is a spontaneous report from a contactable consumer (Patient). A 63-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EP7533), dose 1 via an unspecified route of administration, administered in Arm Left in Apr2021 at 02:30 PM (Age at vaccination: 63 years) as dose 1, single for covid-19 immunisation. Patient had known allergies to penicillin, sulfa, ibuprofen, flu vaccine, chocolate, pepper, citrus, chemical senitiviies. Other medical history included asthma, IBS, allergies. Concomitant medications included vitamin d [vitamin d nos] (VITAMIN D [VITAMIN D NOS]). Patient did not receive other vaccines in 4 weeks. The patient experienced raised heart rate to 90+bpm, gi nausea, shortness of breath, rash on legs/ rash on both arms and torso, itching, loose bowel movement, fatigue, red fingertips/bright red palms, red nail area, purple fingers to knuckle area in Apr2021. Immediately after injection raised heart rate to 90+bpm, GI Nausea. Within 5 minutes shortness of breath occured. 50mg of Benadryl (Diphenhydra-mine HCL) within 10 minutes of vaccine was given. Heart rate decreased to 79 bpm; shortness of breath was decreased within 25 minutes of first Benadryl dose. Rash on legs first 30 mins. Heart monitored at ER for two hours with no incident found. Pulse after discharge was 88 and blood pressure was at 164/86. There was Rash on both arms and torso later in the day along with itching. Aggressive rash/itching continued on arms for 4 for days requiring Benadryl 50mg/4 hours. Day 5 Benadryl reduced to 50mg/6 hour then 8 hours and by day 6 rash was gone. Shortness of breath subsided within 2 hours. Nausea resulted in 1 loose bowel movement within first hour post vaccine with no other GI issues. Fatigue was on day 2 only. Covid fingers day 3 thru day 5, with stronger symptoms on left hand. Symptoms changed but included red fingertips, red nail area, purple fingers to knuckle area, bright red palms. Treatment for the events included Benadryl 50mg/4 hour for 4.5 days. Patient did not have COVID prior vaccination. Patient did not test COVID post vaccination. The patient underwent lab tests and procedures which included blood pressure measurement: 164/86 on blood pressure at 164/86, raised heart rate to 90+bpm in Apr2021, heart rate: 79 bpm, Heart rate decreased to 79 bpm, heart rate: pulse after discharge was 88. The outcome of the events was recovered in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: raised heart rate to 90+bpm; GI Nausea; shortness of breath; Rash on legs/ Rash on both arms and torso; Itching; loose bowel movement; Fatigue; red finger tips/bright red palms; red nail area; purple fingers to knuckle area; This is a spontaneous report from a contactable consumer (Patient). A 63-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EP7533), dose 1 via an unspecified route of administration, administered in Arm Left in Apr2021 at 02:30 PM (Age at vaccination: 63 years) as dose 1, single for covid-19 immunisation. Patient had known allergies to penicillin, sulfa, ibuprofen, flu vaccine, chocolate, pepper, citrus, chemical senitiviies. Other medical history included asthma, IBS, allergies. Concomitant medications included vitamin d [vitamin d nos] (VITAMIN D [VITAMIN D NOS]). Patient did not receive other vaccines in 4 weeks. The patient experienced raised heart rate to 90+bpm, gi nausea, shortness of breath, rash on legs/ rash on both arms and torso, itching, loose bowel movement, fatigue, red fingertips/bright red palms, red nail area, purple fingers to knuckle area in Apr2021. Immediately after injection raised heart rate to 90+bpm, GI Nausea. Within 5 minutes shortness of breath occured. 50mg of Benadryl (Diphenhydra-mine HCL) within 10 minutes of vaccine was given. Heart rate decreased to 79 bpm; shortness of breath was decreased within 25 minutes of first Benadryl dose. Rash on legs first 30 mins. Heart monitored at ER for two hours with no incident found. Pulse after discharge was 88 and blood pressure was at 164/86. There was Rash on both arms and torso later in the day along with itching. Aggressive rash/itching continued on arms for 4 for days requiring Benadryl 50mg/4 hours. Day 5 Benadryl reduced to 50mg/6 hour then 8 hours and by day 6 rash was gone. Shortness of breath subsided within 2 hours. Nausea resulted in 1 loose bowel movement within first hour post vaccine with no other GI issues. Fatigue was on day 2 only. Covid fingers day 3 thru day 5, with stronger symptoms on left hand. Symptoms changed but included red fingertips, red nail area, purple fingers to knuckle area, bright red palms. Treatment for the events included Benadryl 50mg/4 hour for 4.5 days. Patient did not have COVID prior vaccination. Patient did not test COVID post vaccination. The patient underwent lab tests and procedures which included blood pressure measurement: 164/86 on blood pressure at 164/86, raised heart rate to 90+bpm in Apr2021, heart rate: 79 bpm, Heart rate decreased to 79 bpm, heart rate: pulse after discharge was 88. The outcome of the events was recovered in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Galactostasis, Off label use, Product use issue
Clinical narrative: Off label use; Drug use in unapproved population; clogged milk ducts; This is a spontaneous report from a contactable consumer or other non hcp (Patient).   A 36-years-old female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8732), dose 1 via an unspecified route of administration, administered in Arm Right on 06Apr2021 17:00 (at the age of 36 years old) as dose 1, single for covid-19 immunisation. Medical history included from an unknown date and unknown if ongoing. No known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient concomitant medication was not reported. The patient didn't received other medications within 2 weeks of vaccination. Patient stated I am a breast feeding mom. 5 days after receiving the vaccine I began experiencing clogged milk ducts on 06Apr2021 17:00. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were recovering.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021427749 baby case
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Hypoaesthesia, Limb discomfort
Clinical narrative: Muscle and joint pain in upper left arm; Muscle and joint pain in upper left arm; unable to raise left arm as high as my right arm since second vaccine; numbness in left arm while lying on my left side; extreme fatigue; frequent headaches; This is a spontaneous report from a contactable nurse (patient) reported herself that a 36-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, batch/ lot number: unknown), via an unknown route of administration in left arm on 11Jan2021 at 13:15 (at the age of 36-years-old) as single for COVID-19 immunization at hospital. The patient's medical history included ADHD (Attention deficit hyperactivity disorder) and depression; both were from an unknown date to unknown if ongoing. She had no known allergies. Concomitant medications included duloxetine hydrochloride (CYMBALTA) and lisdexamfetamine mesylate (VYVANSE); both were taken for an unknown indication from an unknown date. No other vaccine in four weeks. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, batch/ lot number: unknown), via an unknown route of administration in left arm on 16Dec2020 at 13:00 (at the age of 36-years-old) as single for COVID-19 immunization. On 11Jan2021 at 20:00, the patient experienced muscle and joint pain in upper left arm, unable to raise left arm as high as my right arm since second vaccine, numbness in left arm while lying on my left side, extreme fatigue and frequent headaches. The events resulted in doctor or other healthcare professional office/clinic visit. No COVID prior vaccination. No COVID tested post vaccination. No treatment received. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Muscle and joint pain in upper left arm; Muscle and joint pain in upper left arm; unable to raise left arm as high as my right arm since second vaccine; numbness in left arm while lying on my left side; extreme fatigue; frequent headaches; This is a spontaneous report from a contactable nurse (patient) reported herself that a 36-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, batch/ lot number: unknown), via an unknown route of administration in left arm on 11Jan2021 at 13:15 (at the age of 36-years-old) as single for COVID-19 immunization at hospital. The patient's medical history included ADHD (Attention deficit hyperactivity disorder) and depression; both were from an unknown date to unknown if ongoing. She had no known allergies. Concomitant medications included duloxetine hydrochloride (CYMBALTA) and lisdexamfetamine mesylate (VYVANSE); both were taken for an unknown indication from an unknown date. No other vaccine in four weeks. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, batch/ lot number: unknown), via an unknown route of administration in left arm on 16Dec2020 at 13:00 (at the age of 36-years-old) as single for COVID-19 immunization. On 11Jan2021 at 20:00, the patient experienced muscle and joint pain in upper left arm, unable to raise left arm as high as my right arm since second vaccine, numbness in left arm while lying on my left side, extreme fatigue and frequent headaches. The events resulted in doctor or other healthcare professional office/clinic visit. No COVID prior vaccination. No COVID tested post vaccination. No treatment received. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Throat tightness
Clinical narrative: Chills with chattering teeth.; Tightness in throat; difficulty breathing; lightheadedness; This is a spontaneous report from a contactable consumer. This consumer (patient) reported that, a 50-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 17Apr2021 09:00 (Batch/Lot Number: Ew0162) as dose 2, single (at age of 50-years old) for covid-19 immunization. The patient medical history included allergies to Histamines, FQ drugs, and cigarette smoke from an unknown date and unknown if ongoing. Concomitant medication included vitamin c (ASCORBIC ACID) taken for an unspecified indication, start and stop date were not reported. The patient previously took first dose of bnt162b2 Solution for injection, via an unspecified route of administration, administered in Arm Left on 27Mar 2021 09:00 AM (Batch/Lot Number: En6207) as single dose (at age of 50-years old) for covid-19 immunization. There was no other vaccine in four weeks. No covid prior vaccination and no covid tested post vaccination. The patient experienced chills with chattering teeth, tightness in throat, difficulty breathing, lightheadedness on 18Apr2021. It was reported that, 15 hrs after injection, Chills with chattering teeth and Tightness in throat that would come and go. Lasted 4 hours. Some difficulty breathing (Took Benedryl) Some lightheadedness on 18Apr2021. The patient taken Benedryl for difficulty breathing and no treatment for other events. The outcome of the events was resolving at the time of reporting.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021343956 similar report from same reporter
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dizziness, Heart rate, Heart rate increased
Clinical narrative: tightness in my face; slight lightheadedness; something akin to a hotflash; heart beat became unnervingly very rapid; elevated blood pressure (between 150 and 160 as the upper number with a heart beat of 110 bpm; This is a spontaneous report from a contactable consumer (patient) reported himself. A 37-years-old male patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EW0151), via an unspecified route of administration in left arm on 07Apr2021 at 11:00 (at the age of 37-years-old) as dose 1, single for COVID-19 immunisation. Facility type vaccine reported as other. The patient's medical history was reported as none. No known allergies. The patient concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with Covid-19, prior vaccination. The patient was not tested positive for covid-19, post vaccination. On 07Apr2021 at 11:00, the patient experienced within the first 5 minutes after receiving the shot, I began having tightness in my face, slight lightheadedness, something akin to a hotflash, and my heart beat became unnervingly very rapid. I went with an EMT to get checkout. I was told I had elevated blood pressure (between 150 and 160 as the upper number with a heart beat of 110 bpm- I usually sit between 115/70 and 128/74 and around 68 bpm). I was told my blood oxygen looked normal by the EMT. After about 1-2 hours after the shot, I was fine. My blood pressure and heartbeat returned to my normal levels. The patient did not received treatment for the events. The outcome of the events was recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Hot flush, Oxygen saturation, Skin tightness
Clinical narrative: tightness in my face; slight lightheadedness; something akin to a hotflash; heart beat became unnervingly very rapid; elevated blood pressure (between 150 and 160 as the upper number with a heart beat of 110 bpm; This is a spontaneous report from a contactable consumer (patient) reported himself. A 37-years-old male patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EW0151), via an unspecified route of administration in left arm on 07Apr2021 at 11:00 (at the age of 37-years-old) as dose 1, single for COVID-19 immunisation. Facility type vaccine reported as other. The patient's medical history was reported as none. No known allergies. The patient concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with Covid-19, prior vaccination. The patient was not tested positive for covid-19, post vaccination. On 07Apr2021 at 11:00, the patient experienced within the first 5 minutes after receiving the shot, I began having tightness in my face, slight lightheadedness, something akin to a hotflash, and my heart beat became unnervingly very rapid. I went with an EMT to get checkout. I was told I had elevated blood pressure (between 150 and 160 as the upper number with a heart beat of 110 bpm- I usually sit between 115/70 and 128/74 and around 68 bpm). I was told my blood oxygen looked normal by the EMT. After about 1-2 hours after the shot, I was fine. My blood pressure and heartbeat returned to my normal levels. The patient did not received treatment for the events. The outcome of the events was recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer or other non hcp. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient's concomitant medications and medical history were not reported. The patient experienced shingles on an unspecified date. The outcome of the event was unknown.   No follow-up attempts are needed. Information about Lot/Batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC same reporter/AE/drug, different patient
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Blood pressure measurement, Fall, Fatigue, Malaise
Clinical narrative: malaise; tired/fatigue; everything was "turning black"; blood pressure had bottomed out to 80/52; slumped over; This is a spontaneous report from a contactable Nurse (patient mother). A 17-years-old non pregnant female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration, administered in Arm Right on 11Apr2021 13:15 (Batch/Lot number was not reported) (at the age of 17-year-old) for COVID-19 immunisation. The patient had no other medical history. Patient had no covid prior vaccination. Patient did not receive any other vaccines within 4weeks. Concomitant medications included sulfamethoxazole, trimethoprim (BACTRIM) taken for an unspecified indication, start and stop date were not reported. The patient previously took clindamycin and experienced allergy. On 11Apr2021 13:30 the patient experienced malaise, tired, everything was "turning black", blood pressure had bottomed out to 80/52, fatigued, slumped over. Approximately 5-10 minutes post vaccination, patient began to appear malaise. She complained that she felt extremely tired. Next, she stated that everything was "turning black". The pharmacist who gave the vaccine was no where to be found. Patient mother ran and got the NP at the clinic w/in the pharmacy to check her BP. NP stated to mother that she could not hear a BP. Patient mother asked if she could use her stethoscope to hear a BP, as patient mother a RN. Her blood pressure had bottomed out to 80/52. We got her feet up quickly as she was beginning to look very fatigued and slumped over. Patient mother continued to check her blood pressure after the NP left daughter and patient mother in the waiting area to go and continue to see her other clinic pts. Patient mother called 911 to get her daughter some medical assistance as patient mother was starting to panic. Patient mother continued checking her bp that came up to 82/50 and another recheck of 100/60. The EMT arrived maybe 5 min or so later. She continued to have the normal fatigue x2 days. AE resulted in Doctor or other healthcare professional office/clinic visit. AE treatment included called EMT to vaccine site, hydrated, feet elevated to recover blood pressure back to normal limits. The patient did not tested covid post vaccination. Outcome of the events was recovered in 2021.   Information about lot/batch number has been requested.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: malaise; tired/fatigue; everything was "turning black"; blood pressure had bottomed out to 80/52; slumped over; This is a spontaneous report from a contactable Nurse (patient mother). A 17-years-old non pregnant female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration, administered in Arm Right on 11Apr2021 13:15 (Batch/Lot number was not reported) (at the age of 17-year-old) for COVID-19 immunisation. The patient had no other medical history. Patient had no covid prior vaccination. Patient did not receive any other vaccines within 4weeks. Concomitant medications included sulfamethoxazole, trimethoprim (BACTRIM) taken for an unspecified indication, start and stop date were not reported. The patient previously took clindamycin and experienced allergy. On 11Apr2021 13:30 the patient experienced malaise, tired, everything was "turning black", blood pressure had bottomed out to 80/52, fatigued, slumped over. Approximately 5-10 minutes post vaccination, patient began to appear malaise. She complained that she felt extremely tired. Next, she stated that everything was "turning black". The pharmacist who gave the vaccine was no where to be found. Patient mother ran and got the NP at the clinic w/in the pharmacy to check her BP. NP stated to mother that she could not hear a BP. Patient mother asked if she could use her stethoscope to hear a BP, as patient mother a RN. Her blood pressure had bottomed out to 80/52. We got her feet up quickly as she was beginning to look very fatigued and slumped over. Patient mother continued to check her blood pressure after the NP left daughter and patient mother in the waiting area to go and continue to see her other clinic pts. Patient mother called 911 to get her daughter some medical assistance as patient mother was starting to panic. Patient mother continued checking her bp that came up to 82/50 and another recheck of 100/60. The EMT arrived maybe 5 min or so later. She continued to have the normal fatigue x2 days. AE resulted in Doctor or other healthcare professional office/clinic visit. AE treatment included called EMT to vaccine site, hydrated, feet elevated to recover blood pressure back to normal limits. The patient did not tested covid post vaccination. Outcome of the events was recovered in 2021.   Information about lot/batch number has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Malaise
Clinical narrative: Wasn't feeling well; Shingles; This is a spontaneous report from a contactable consumer. This 39 year-old non-pregnant female consumer (Patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EL0142) via an unspecified route of administration on 05Jan2021 at 04;30 PM (at 39-year-old) in left arm as dose 1, single for COVID-19 immunization. The patient had no medical history and no allergies. The patient received Healther birth control pills in two weeks. It was mentioned that no other vaccine was received in four weeks, the patient did not have Covid prior vaccination and was not tested for covid post vaccination. Two weeks after the first dose on 20Jan2021 at 01:00 pm patient was not feeling well and went to (withheld) Urgent Care and was diagnosed with Shingles. She had never had Shingles and also did not have any underlying illnesses. The event resulted in emergency room visit. She was treated with Valtrex for events. On an unknown date in 2021 the patient recovered.  No follow-up attempts were possible. No further information was expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report received from a contactable consumer or other non-health care professional (patient). A 47-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6955), via an unspecified route of administration, administered in Arm Left on 20Mar2021 17:45 (at the age of 47-years-old) as dose 1, single for COVID-19 immunisation. Medical history included chickenpox virus from an unknown date and unknown if ongoing. Concomitant medications included levothyroxine sodium (LEVOTHYROXINE SODIUM), fluticasone propionate, salmeterol xinafoate (ADVAIR), fluticasone (FLUTICASONE) taken for an unspecified indication, start and stop date were not reported. The patient previously took Symbicort and experienced hypersensitivity. The patient experienced shingles on 23Mar2021. Patient received treatment Medication for the chickenpox virus, pain and gel. Patient visited Emergency room/department or urgent care. The outcome of the events was reported as recovering.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (patient himself). A 46-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via unspecified route of administration, in left arm on 09Mar2021 09:45 (age at vaccination: 46-years-old) as dose 2, single for covid-19 immunisation. Historical vaccine included first dose of BNT162B2 (Lot number: EL3247), via unspecified route of administration, in left arm on 17Feb2021 09:45 AM as dose 1, single for covid-19 immunisation. Facility type vaccine was workplace clinic. Medical history of patient was not reported. No other vaccine in four weeks was administered to the patient. Concomitant medication included Acutane 10mg, taken for unspecified indication, start and stop date unknown. Patient had no known allergies. On 25Mar2021 15:00, patient experienced shingles. The event resulted in doctor or other healthcare professional office/clinic visit. No treatment regimen was given as a result of the adverse events. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of event was recovering.   No Follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Papule, Pruritus
Clinical narrative: A zone of papules and pruritis suggestive of shingles; A zone of papules and pruritis suggestive of shingles; A zone of papules and pruritis suggestive of shingles; This is a spontaneous report from a contactable Other HCP. A 72-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6208), via an unspecified route of administration on 13Mar2021 at 10:00 am (at the age of 72-years-old) into Arm Left as a single dose for COVID-19 immunization at clinic. The patient had received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9266), via an unspecified route of administration on 20Feb2021 at 10:00 am into left arm as a single dose for COVID-19 immunization at clinic. Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing Verbatim. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies. On 16Apr2021, the patient experienced A zone of papules and pruritis suggestive of shingles. No treatment was given for the events. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: Headache- day 9th; fever; chills; diarrhea; nausea; muscle and joint pain; muscle and joint pain; injection site pain; exhaustion; feeling unwell; rash on my neck; This is a spontaneous report from a non-contactable consumer (patient) reported herself. A 43-years-old non-pregnant female patient received second dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, lot number: ER 8829), via an unknown route of administration in left arm on 10Apr2021 (at the age of 43-years-old) as dose 2, single for Covid-19 immunisation at hospital. The patient's medical history included seasonal allergies and hazelnuts allergy. Concomitant medications included cetirizine hydrochloride [ZYRTEC (CETIRIZINE HYDROCHLORIDE)], bupropion (BUPROPION), phentermine (PHENTERMINE); were taken for an unknown indication from an unknown date. The patient previously received first dose of BNT162B2 as historical vaccine (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, lot number: ER 8727), via an unknown route of administration in left arm on 20Mar2021 at 08:00 (at the age of 43-years-old) as dose 1, single for Covid-19 immunisation. No other vaccine in four weeks. On 11Apr2021 at 01:00, the patient experienced headache- day 9th (For first 3 days, headache), fever, chills, diarrhea, nausea, muscle and joint pain, injection site pain, exhaustion, feeling unwell, rash on my neck. Event resulted in visit to doctor or other healthcare professional office/clinic. No covid prior vaccination. No covid tested post vaccination. Migraine pills received as treatment. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Nausea, Pyrexia, Rash
Clinical narrative: Headache- day 9th; fever; chills; diarrhea; nausea; muscle and joint pain; muscle and joint pain; injection site pain; exhaustion; feeling unwell; rash on my neck; This is a spontaneous report from a non-contactable consumer (patient) reported herself. A 43-years-old non-pregnant female patient received second dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, lot number: ER 8829), via an unknown route of administration in left arm on 10Apr2021 (at the age of 43-years-old) as dose 2, single for Covid-19 immunisation at hospital. The patient's medical history included seasonal allergies and hazelnuts allergy. Concomitant medications included cetirizine hydrochloride [ZYRTEC (CETIRIZINE HYDROCHLORIDE)], bupropion (BUPROPION), phentermine (PHENTERMINE); were taken for an unknown indication from an unknown date. The patient previously received first dose of BNT162B2 as historical vaccine (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, lot number: ER 8727), via an unknown route of administration in left arm on 20Mar2021 at 08:00 (at the age of 43-years-old) as dose 1, single for Covid-19 immunisation. No other vaccine in four weeks. On 11Apr2021 at 01:00, the patient experienced headache- day 9th (For first 3 days, headache), fever, chills, diarrhea, nausea, muscle and joint pain, injection site pain, exhaustion, feeling unwell, rash on my neck. Event resulted in visit to doctor or other healthcare professional office/clinic. No covid prior vaccination. No covid tested post vaccination. Migraine pills received as treatment. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Headache- day 9th; fever; chills; diarrhea; nausea; muscle and joint pain; muscle and joint pain; injection site pain; exhaustion; feeling unwell; rash on my neck; This is a spontaneous report from a non-contactable consumer (patient) reported herself. A 43-years-old non-pregnant female patient received second dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, lot number: ER 8829), via an unknown route of administration in left arm on 10Apr2021 (at the age of 43-years-old) as dose 2, single for Covid-19 immunisation at hospital. The patient's medical history included seasonal allergies and hazelnuts allergy. Concomitant medications included cetirizine hydrochloride [ZYRTEC (CETIRIZINE HYDROCHLORIDE)], bupropion (BUPROPION), phentermine (PHENTERMINE); were taken for an unknown indication from an unknown date. The patient previously received first dose of BNT162B2 as historical vaccine (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, lot number: ER 8727), via an unknown route of administration in left arm on 20Mar2021 at 08:00 (at the age of 43-years-old) as dose 1, single for Covid-19 immunisation. No other vaccine in four weeks. On 11Apr2021 at 01:00, the patient experienced headache- day 9th (For first 3 days, headache), fever, chills, diarrhea, nausea, muscle and joint pain, injection site pain, exhaustion, feeling unwell, rash on my neck. Event resulted in visit to doctor or other healthcare professional office/clinic. No covid prior vaccination. No covid tested post vaccination. Migraine pills received as treatment. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (patient). A 72-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FL1283, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 26Jan2021 (at the age of 72-year-old) as dose 1, single for COVID-19 immunization. The patient medical history included allergies (known allergies). Concomitant medication included levothyroxine (LEVOTHYROXINE). The patient received unspecified other vaccine in four weeks. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. On 06Feb2021, the patient experienced shingles. The event resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received for the event. The outcome of the event was reported as resolved on an unspecified date in 2021.  No Follow-up attempts are possible. No Further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: Low grade fever (99); very tired; Chills; muscle pain; Joint pain; headache; Sore arm; Injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 11Apr2021 at 16:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issue. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) and nigella sativa seed oil (black cumin seed oil) (MANUFACTURER UNKNOWN) all from unknown date for unknown indication. The patient previously took Aspirin and experienced allergy to it. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 21Mar2021 at 16:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. On 11Apr2021, within a few minutes, the patient experienced injection site pain. On 12Apr2021 at 09:00, the patient experienced low grade fever (99) after 18 hours, tired, chills, muscle pain by 24 hours, joint pain, headache by 27 hours, very tired, and sore arm. Therapeutic measures were not taken for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent. On 12Apr2021, the patient underwent body temperature and the result was 99 (unspecified units). The clinical outcome of the event injection site pain, low grade fever (99), chills, muscle pain was resolved in Apr2021, joint pain and headache was resolved on 13Apr2021, very tired was resolved on 14Apr2021 and sore arm was resolved on 15Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.